We then found that metastatic CRC overexpressing miRNA‐483‐3p hyperactivates EGFR/ERBB3 signaling in a ligand‐independent manner, leading to constitutive activation of EMT via the AKT/GSK3β/EMT transcription factors axis. The gene discussed is ERBB3; the disease is colorectal carcinoma.